Pathophysiology of Type 2 Diabetes Flashcards

(33 cards)

1
Q

What factors contribute to the development of insulin resistance?

A

Genetic predisposition and obesity lifestyle factors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What does insulin resistance cause?

A

Compensatory beta cell hyperplasia, leading to beta cell failure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What does early beta cell failure cause?

A

Impaired glucose tolerance = progresses to diabetes as beta cell failure progresses

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are the factors linked to hyperglycaemia?

A

Increased incretin effect, decreased insulin secretion
increased lipolysis, increased glucose reabsorption, neurotransmitter dysfunction, decreased glucose uptake, increased hepatic glucose production, increased glucagon secretion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What contributes to the susceptibility of an individual to type 2 diabetes?

A

Genetic component, foetal development, postnatal nutrition

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What adaptions occur in the cells during type 2 diabetes?

A

Beta cell mass expansion, insulin secretion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Failure of what processes are linked to type 2 diabetes?

A

Glucolipotoxicity, oxidative stress, ER stress, de-differentiation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

How do weight and insulin resistance change as the disease progresses?

A

They both increase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What affect does obesity have on disease progression?

A

It accelerates the disease presentation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is type 2 diabetes a disease of in most people?

A

Disease of beta cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

How does beta cell dysfunction cause microvascular disease?

A

Beta cell dysfunction causes hyperglycaemia = chronic hyperglycaemia leads to microvascular disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

How can progression of microvascular disease be reduced?

A

By intensive glucose control

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

How is CVD risk best treated?

A

Through use of statins and anti-hypertensives

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is the first step of treating someone with type 2 diabetes?

A

Lifestyle advice = information, reduce weight by 5-10%, give exercise target
Medications = metformin, may need statin/ACE inhibitor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What does metformin do?

A

Decreases hepatic gluconeogenesis = increases peripheral glucose uptake

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are the adverse effects of metformin?

A

GI effects, lactic acidosis

17
Q

What are the diabetic outcome of metformin?

A

Reduce HbA1c by 0.8-2.0%
Get weight to neutral
No hypoglycaemia

18
Q

What are factors that lead to failure to meet glycaemic targets?

A

Younger patient, female, obese, not at BP/lipid targets, more complex glucose lowering therapy, poor adherence to drugs and lifestyle changes

19
Q

What is the first step of drug prescription for type 2 diabetes?

A

Metformin

Sulphonylurea if intolerant to metformin

20
Q

What is the second step of drug prescription for type 2 diabetes?

A

Add sulphonylurea
Use TZD if hypoglycaemia a concern
Use DPPIV if weight gain a concern

21
Q

What is the third step of drug prescribing for type 2 diabetes?

A

Add TZD
Use DPPIV if weight gain a concern
Use insulin if osmotic symptoms or rising HbA1c
Use GLP-1 if BMI > 30mg/kg

22
Q

How should glycaemic targets be created?

A

Must be individualised, as should glucose lowering therapies

23
Q

What is the optimal first line drug for treating type 2 diabetes?

A

Metformin (unless contra-indicated)

24
Q

What is the foundation of any type 2 diabetes treatment programme?

A

Diet, exercise and education

25
What should be the major focus of therapy for type 2 diabetics?
Comprehensive CV risk reduction
26
How does sulphonylurea act?
Blocks beta cell KATP channels = increases first and second phase insulin secretion Efficacy reduced at higher doses
27
What are the diabetic outcomes for sulphonylurea?
Reduce HbA1c by 1.0-2.0% Increase weight gain by 2kg Increase hypoglycaemia
28
What are the adverse effects of sulphonylurea?
Abnormal LFTs, increased CHD
29
What are some features of GLP-1 and DPPIV?
``` GLP-1 = injected, affects hypoglycaemia when used in combination DPPIV = oral, weight stays the same or decreases ```
30
How does glitazone work?
PPAR gamma inhibitor = increases peripheral glucose uptake
31
What are the diabetic outcome for glitazone?
Decrease HbA1c by 0.6-1.5% | Increase weight gain by 3.5 kg
32
What are the adverse effects of glitazone?
Fracture risk increase, hepatotoxicity, fluid retention
33
What is the general treatment plan for type 2 diabetics?
Therapeutic lifestyle change = results in remission in 10-15% Monotherapy Combination therapy (not insulin) Combination therapy with insulin